OOIR: Observatory of International Research

Papers

(The TQCC of Allergy and Asthma Proceedings is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	76
Association of EDN levels in patients with asthma and correlation with FEV₁%: A meta-analysis	69
COVID-19: A continuing challenge for the allergist/immunologist	41
Factors associated with treatment response in eosinophilic esophagitis patients: Experience from a pediatric tertiary care center	31
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis	30
To test or not to test: Lessons learned from screening infants for peanut allergy	28
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab	23
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist	22
Operationalizing shared decision making in clinical practice	21
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol	20
Food protein‐induced enterocolitis syndrome: Current practices in oral food challenge	19
Not all marketed skin cleansers’ pH is optimal for atopic dermatitis	19
Future directions in allergen immunotherapy	19
Cold-induced urticaria in children: A multicenter, retrospective cohort study	18
The association of timothy grass allergy and cat ownership on cat sensitization	18
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study	18
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	18
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber	16
For the Patient	16
Safety of ciclesonide in children with asthma: A review of randomized controlled trials	16
Venom allergen immunotherapy	16
A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children	16
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery	16
The role of component-resolved diagnosis in Hymenoptera venom allergy in clinical practice	16
Predictors of anaphylaxis to peanut and tree nuts in a Mediterranean population	15

For the Patient	15
Impact of steroids on the immune profiles of children with asthma living in the inner-city	14
Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis	14
Caregiver perceptions and attitudes associated with oral immunotherapy on social media	14
Prevalence of neurological diseases among patients with selective IgA deficiency	13
Efficacy and safety of sublingual allergen immunotherapy	13
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS	13
Cost assessment of allergy procedures to improve high-value care implementation	13
Health disparities in hymenoptera venom allergy management	12
Shifts in allergy practice in a COVID-19 world: Implications of pre‐COVID-19 national health care provider and patient surveys of treatments for nasal allergies	12
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	12
Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia	11
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	11
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	11
Evaluation of nasal symptoms to distinguish eosinophilic from noneosinophilic nasal polyps based on peripheral blood	11
Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy	11
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level	10
COVID-19 in Italian children and adolescents: The role of allergy and asthma	10
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	10
Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma	10
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	10
Immunodeficiency: Overview of primary immune regulatory disorders (PIRDs)	10
Longitudinal experience with treatment of acquired angioedema using tranexamic acid	10
Integrating innovation and shared decision-making in allergy and immunology practice	9
Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review	9
Do commercial dog extracts cross-react with Felis domesticus allergen 1	9
Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema	9
How important is patch testing with dental materials in real-life clinical practice?	9
Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study	9
For the patient	8
Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients	8
Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure	8
Management and referral patterns for new-onset chronic cough in primary care patients	8
For the Patient	8
Idiopathic non-mast cell angioedema: Treatment insights from global experts	8
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy	8
Female sex as a risk factor for penicillin drug allergy in the inpatient setting	8
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2	8
For the Patient	8
For the Patient	7
The influence of sea breeze on mold spore dispersion	7
For the patient	7
Curcumin does not significantly affect immediate skin tests	7
Abstracts presented at the Eastern Allergy Conference May 30‐June 2, 2024, Palm Beach, Florida	7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	7
Evaluation and management of adverse reactions to the COVID-2019 vaccines	7
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii	7
Can clinical characteristics differentiate patients with unexplained chronic cough from patients with asthma and COPD?	7
Assessing cross-reactivity in allergen immunotherapy	7
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	7

TEV/FEV₃ as a coherent metric of small airway dysfunction in childhood asthma	7
Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist	7
The relationship between childhood atopic dermatitis and asthma in an under resourced community	7
A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending	6
For the Patient	6
Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic	6
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	6
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	6
Does vitamin D deficiency in asthma affect clinical and functional parameters? A Turkish multicenter study	6
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children	6
Allergic diseases in children: A continuing challenge for the Allergist-Immunologist	6
For the Patient	6
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	6
Dupilumab rapidly improves eustachian tube dysfunction and otologic symptoms in aspirin-exacerbated respiratory disease	6
Bronchial provocation test measured by using the forced oscillation technique to assess airway responsiveness	6
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	5
A 48-year-old female with perioperative anaphylaxis	5
Evaluation and management of chronic cough in adults	5
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19	5
Current and emerging therapies for eosinophilic esophagitis	5
Standardized allergen extracts for allergen immunotherapy	5
Mast cell activation syndrome: Myths and realities	5
Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?	5
Pearls and pitfalls in food protein-induced enterocolitis syndrome (FPIES)	5
Clinical features, severity, and immunological changes during venom immunotherapy in children and adults	5
The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency	5
Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non‐tertiary care private practice setup	5
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	5
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?	5
Clinical phenotypes of childhood food allergies based on immune mechanisms: A multicenter study	5
An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy	5
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	5
For the Patient	5
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs	5
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	5
Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge	5